CalciMedica, Inc. (CALC) vs Dermata Therapeutics, Inc. (DRMA)
A side-by-side comparison of CalciMedica, Inc. and Dermata Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CALC
CalciMedica, Inc.
$1.44HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
DRMA
Dermata Therapeutics, Inc.
$1.13HealthcareDelayed quote: Oct 6, 2026, 10:37 AM EDT
Total return — CALC vs DRMA
growth of $100 · dividends reinvested · last 3yCALC -94.7% (-62.5%/yr)DRMA -99.6% (-84.0%/yr)CALC compounded faster over this window
Log scale — wide-divergence pair
CALC DRMA
CALC vs DRMA: by the numbers
- •DRMA is the larger company ($5M vs $5M market cap).
Metrics side by side
Valuation
| Metric | CALC | DRMA |
|---|---|---|
| P/B ratio | 0.82 | 1.30 |
Profitability
| Metric | CALC | DRMA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -385.27% | -239.95% |
| ROIC | -122.56% | -246.61% |
Growth (annualized)
| Metric | CALC | DRMA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -83.90% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.